| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |